» Articles » PMID: 23971908

Sequence-specific Cleavage of BM2 Gene Transcript of Influenza B Virus by 10-23 Catalytic Motif Containing DNA Enzymes Significantly Inhibits Viral RNA Translation and Replication

Overview
Date 2013 Aug 27
PMID 23971908
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

One of the hallmarks of progression of influenza virus replication is the step involving the virus uncoating that occurs in the host cytoplasm. The BM2 ion channel protein of influenza B virus is highly conserved and is essentially required during the uncoating processes of virus, thus an attractive target for designing antiviral drugs. We screened several DNA enzymes (Dzs) containing the 10-23 catalytic motif against the influenza B virus BM2 RNA. Dzs directed against the predicted single-stranded bulge regions showed sequence-specific cleavage activities. The Dz209 not only showed significant intracellular reduction of BM2 gene expression in transient-expression system but also provided considerable protection against influenza B virus challenge in MDCK cells. Our findings suggest that the Dz molecule can be used as selective and effective inhibitor of viral RNA replication, and can be explored further for development of a potent therapeutic agent against influenza B virus infection.

Citing Articles

Antiviral options and therapeutics against influenza: history, latest developments and future prospects.

Meseko C, Sanicas M, Asha K, Sulaiman L, Kumar B Front Cell Infect Microbiol. 2023; 13:1269344.

PMID: 38094741 PMC: 10716471. DOI: 10.3389/fcimb.2023.1269344.


A promising nucleic acid therapy drug: DNAzymes and its delivery system.

Xiao L, Zhao Y, Yang M, Luan G, Du T, Deng S Front Mol Biosci. 2023; 10:1270101.

PMID: 37753371 PMC: 10518456. DOI: 10.3389/fmolb.2023.1270101.


Emerging Influenza D Virus Threat: What We Know so Far!.

Asha K, Kumar B J Clin Med. 2019; 8(2).

PMID: 30764577 PMC: 6406440. DOI: 10.3390/jcm8020192.


Advancements in Nucleic Acid Based Therapeutics against Respiratory Viral Infections.

Asha K, Kumar P, Sanicas M, Meseko C, Khanna M, Kumar B J Clin Med. 2018; 8(1).

PMID: 30577479 PMC: 6351902. DOI: 10.3390/jcm8010006.


The emerging influenza virus threat: status and new prospects for its therapy and control.

Kumar B, Asha K, Khanna M, Ronsard L, Meseko C, Sanicas M Arch Virol. 2018; 163(4):831-844.

PMID: 29322273 PMC: 7087104. DOI: 10.1007/s00705-018-3708-y.